Front Row Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-480
Closed -$10.8K 562
2024
Q2
$10.8K Hold
480
﹤0.01% 550
2024
Q1
$12.6K Buy
+480
New +$13.7K ﹤0.01% 522
2023
Q4
Sell
-480
Closed -$13.5K 535
2023
Q3
$13.5K Hold
480
0.01% 455
2023
Q2
$18K Hold
480
0.01% 401
2023
Q1
$14K Hold
480
0.01% 445
2022
Q4
$15K Hold
480
0.01% 421
2022
Q3
$12K Hold
480
0.01% 459
2022
Q2
$15K Hold
480
0.01% 439
2022
Q1
$15K Hold
480
0.01% 466
2021
Q4
$16K Hold
480
0.01% 471
2021
Q3
$14K Hold
480
0.01% 484
2021
Q2
$15K Hold
480
0.01% 475
2021
Q1
$13K Hold
480
0.01% 489
2020
Q4
$12K Hold
480
0.01% 473
2020
Q3
$12K Hold
480
0.01% 464
2020
Q2
$7K Hold
480
﹤0.01% 545
2020
Q1
$6K Hold
480
﹤0.01% 567
2019
Q4
$9K Hold
480
0.01% 472
2019
Q3
$7K Hold
480
0.01% 514
2019
Q2
$12K Hold
480
0.01% 401
2019
Q1
$18K Hold
480
0.01% 336
2018
Q4
$14K Hold
480
0.01% 342
2018
Q3
$15K Hold
480
0.01% 349
2018
Q2
$22K Hold
480
0.01% 319
2018
Q1
$23K Hold
480
0.02% 314
2017
Q4
$24K Buy
+480
New +$25.1K 0.02% 317

Other funds holding CC

Front Row Advisors's CC Position: Q3 2024 in Review

Front Row Advisors sold out of Chemours (CC) in Q3 2024, closing a stake of 480 shares — an estimated $10.8K sold.

Front Row Advisors first reported a position in CC in Q4 2017 and held it in 26 quarters. The position peaked at $24K in Q4 2017. 421 funds tracked by Wall St. Rank hold CC as of Q3 2024.

  • Front Row Advisors reported no remaining Chemours position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 480 Chemours shares in Q3 2024, an estimated $10.8K.
  • Front Row Advisors first reported a position in Chemours in Q4 2017 and held it in 26 quarters.
  • Front Row Advisors's Chemours position peaked at $24K in Q4 2017.
  • 421 funds tracked by Wall St. Rank held Chemours as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.